Low-irradiance UV causes measurable DNA damage in human skin without erythema

The randomized, within-subject trial exposed 2 cm² back sites to solar-simulated UV at irradiances matching 9 a.m. versus noon conditions across multiple days, keeping total dose constant. Biopsies obtained 24 h post-exposure quantified DNA lesions by immunohistochemistry and assessed immune markers; damage occurred below the minimal erythemal dose in both arms, contradicting prior assumptions that only peak UV indices matter.

Current Australian guidelines trigger sun protection at UV index ≥3, yet the study demonstrates that sub-erythemal exposures accumulated during routine outdoor activity produce the same molecular initiating events that drive keratinocyte carcinogenesis. This aligns with IARC classification of solar UV as a complete carcinogen and with large cohort data linking cumulative dose, not intensity alone, to squamous-cell carcinoma incidence.

If replicated in darker skin types and longer-term follow-up, the findings imply daily broad-spectrum SPF use even at low UV indices, shifting emphasis from time-of-day avoidance to total-dose minimization. Next studies must quantify cancer endpoints rather than surrogate markers and test behavior-change interventions under revised messaging.